Post Buy Requirement
Pragati Healthcare
Delhi, India
gstGST : 09AUVPG8371K1ZQ Add Review

Products / Services #4320583

Hepcinat LP

22,500 /Box Get Latest Price
  • Min. Order (MOQ) 3 Box
  • Disease Name Hepatitis C
Natco Hepcinat LP (Ledipasvir + Sofosbuvir) - Harvoni is a new medication used to treat hepatitis C. It is a combination pill containing sofosbuvir (sold separately as Sovaldi) plus ledipasvir. It was approved in Europe in November 2014 for treatment of adults with genotype 1 or 4 chronic hepatitis C, and for some people with genotype 3. For many people with these genotypes, Harvoni is an interferon-free and ribavirin-free hepatitis C treatment option. Some people with harder-to-treat disease may do better if they add ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.

Additional Information:

Payment Terms : L/C, D/P, T/T,

Packaging Details : NA

Delivery Time : 5 - 10 days

View Complete Details

Hepcinat 400 Mg

13,500 /Box Get Latest Price
  • Min. Order (MOQ) 3 Pack(s)
  • Disease Name Hepatitis C
Sofosbuvir (brand name Sovaldi) is a new medication used to treat hepatitis C. It was approved in Europe in January 2014 for treatment of adults with all genotypes of chronic hepatitis C. For some people, sofosbuvir will be the first interferon-free hepatitis C treatment option. For others, sofosbuvir can greatly shorten treatment when added to pegylated interferon and ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.

Additional Information:

Payment Terms : L/C, T/T,

Packaging Details : NA

Delivery Time : 5 - 10 days

View Complete Details

Natdac 60 Mg

3,150 /Box Get Latest Price
  • Min. Order (MOQ) 3 Box
  • Disease Name Hepatitis C
Natdac or Daclatasvir (brand name Daklinza) is a new medication used to treat hepatitis C. It was approved in Europe in January 2014 for treatment of adults with all genotypes of chronic hepatitis C. For some people, sofosbuvir will be the first interferon-free hepatitis C treatment option. For others, sofosbuvir can greatly shorten treatment when added to pegylated interferon and ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.Contact us - exports@pragatihc.com

Additional Information:

Payment Terms : L/C, D/P, T/T,

Packaging Details : NA

Delivery Time : 5-10 days

View Complete Details

Velpanat

15,500 /Box Get Latest Price
  • Min. Order (MOQ) 3 Box
  • Disease Name Hepatitis C
Velpanat (sofosbuvir + velpatasvir) - epclusa is a new medication used to treat hepatitis c. It is a combination pill containing sofosbuvir (sold separately as sovaldi) plus velpatasvir. It was approved in europe in july 2016 for treatment of adults with all genotypes (1, 2, 3, 4, 5 and 6) of chronic hepatitis c. Epclusa is the first pangenotypic interferon-free hepatitis c treatment regimen, meaning it works against all hepatitis c genotypes. It is more effective than the older harvoni combination (sofosbuvir + ledipasvir) for people with genotype 3. Some people with harder-to-treat disease may do better if they take epclusa with ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis c such as liver cancer or needing a liver transplant.

Additional Information:

Payment Terms : L/C, D/P, T/T,

Packaging Details : NA

Delivery Time : 5 - 10 days

View Complete Details

Carmustine Injection

  • Min. Order (MOQ) 3 Pack(s)

Generic Name-Carmustine, Marketed By-Emcure Pharmaceuticals Ltd, Pack Size-1 Injection, Primary Use-Brain Tumor

Additional Information:

Packaging Details : 1 Injection

View Complete Details

Oxaliplatin Injection

  • Min. Order (MOQ) 3 Pack(s)

Generic Name-Oxaliplatin, Marketed By-Cipla Ltd, Pack Size-1 Injection, Primary Use-Colon Cancer

Additional Information:

Packaging Details : 1 Injection

View Complete Details

Specialty Pharmaceutical Product Registration

We have a good basket of fast-moving specialty products available for product registration in your region for your exclusive marketing. Our partner manufacturing facilities are USFDA/EMEA/PICs/WHO-GMP certified. We provide dossiers for product registration. Our range includes specialty products of Oncology, Nephrology , HIV, Hepatitis, and other specialty segments.
View Complete Details
Tell Us What are you looking for? Will call you back

Contact Us

  • Nihit Goyal (Pragati Healthcare)
  • Marketing Office - 18, Netaji Subhash Marg, Daryaganj, New Delhi - 110002 rnRegistered Office - 208/A11, Rama Palace, M.G. Road, Agra - 282002
  • Share us via
  • Call 08069182071 Ext. 509
Browse Products / Services list of Pragati Healthcare Delhi, Delhi
Post Buy Requirement
Pragati Healthcare

Pragati Healthcare Delhi

Delhi, India
gstGST : 09AUVPG8371K1ZQ Add Review

Our Product / Services

  1. Pharmaceuticals Tablets

    2 Products available
  2. Anti Infective Medicines & Drugs

    1 Products available
  3. Hepatitis / HCV

    1 Products available
  4. Vaccines

    1 Products available
  5. Anti-Cancer / Oncology

    1 Products available
  6. Others Products / Services 1 Products / Services available

Products / Services #4320583

Leading Manufacturer, Supplier & Retailer of Specialty Pharmaceutical Product Registration.

Hepcinat LP

22,500 /Box Get Latest Price
  • Min. Order (MOQ) 3 Box
  • Disease Name Hepatitis C
Natco Hepcinat LP (Ledipasvir + Sofosbuvir) - Harvoni is a new medication used to treat hepatitis C. It is a combination pill containing sofosbuvir (sold separately as Sovaldi) plus ledipasvir. It was approved in Europe in November 2014 for treatment of adults with genotype 1 or 4 chronic hepatitis C, and for some people with genotype 3. For many people with these genotypes, Harvoni is an interferon-free and ribavirin-free hepatitis C treatment option. Some people with harder-to-treat disease may do better if they add ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.

Additional Information:

Payment Terms : L/C, D/P, T/T,

Packaging Details : NA

Delivery Time : 5 - 10 days

View Complete Details

Hepcinat 400 Mg

13,500 /Box Get Latest Price
  • Min. Order (MOQ) 3 Pack(s)
  • Disease Name Hepatitis C
Sofosbuvir (brand name Sovaldi) is a new medication used to treat hepatitis C. It was approved in Europe in January 2014 for treatment of adults with all genotypes of chronic hepatitis C. For some people, sofosbuvir will be the first interferon-free hepatitis C treatment option. For others, sofosbuvir can greatly shorten treatment when added to pegylated interferon and ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.

Additional Information:

Payment Terms : L/C, T/T,

Packaging Details : NA

Delivery Time : 5 - 10 days

View Complete Details

Natdac 60 Mg

3,150 /Box Get Latest Price
  • Min. Order (MOQ) 3 Box
  • Disease Name Hepatitis C
Natdac or Daclatasvir (brand name Daklinza) is a new medication used to treat hepatitis C. It was approved in Europe in January 2014 for treatment of adults with all genotypes of chronic hepatitis C. For some people, sofosbuvir will be the first interferon-free hepatitis C treatment option. For others, sofosbuvir can greatly shorten treatment when added to pegylated interferon and ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.Contact us - exports@pragatihc.com

Additional Information:

Payment Terms : L/C, D/P, T/T,

Packaging Details : NA

Delivery Time : 5-10 days

View Complete Details

Velpanat

15,500 /Box Get Latest Price
  • Min. Order (MOQ) 3 Box
  • Disease Name Hepatitis C
Velpanat (sofosbuvir + velpatasvir) - epclusa is a new medication used to treat hepatitis c. It is a combination pill containing sofosbuvir (sold separately as sovaldi) plus velpatasvir. It was approved in europe in july 2016 for treatment of adults with all genotypes (1, 2, 3, 4, 5 and 6) of chronic hepatitis c. Epclusa is the first pangenotypic interferon-free hepatitis c treatment regimen, meaning it works against all hepatitis c genotypes. It is more effective than the older harvoni combination (sofosbuvir + ledipasvir) for people with genotype 3. Some people with harder-to-treat disease may do better if they take epclusa with ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis c such as liver cancer or needing a liver transplant.

Additional Information:

Payment Terms : L/C, D/P, T/T,

Packaging Details : NA

Delivery Time : 5 - 10 days

View Complete Details

Carmustine Injection

  • Min. Order (MOQ) 3 Pack(s)

Generic Name-Carmustine, Marketed By-Emcure Pharmaceuticals Ltd, Pack Size-1 Injection, Primary Use-Brain Tumor

Additional Information:

Packaging Details : 1 Injection

View Complete Details

Oxaliplatin Injection

  • Min. Order (MOQ) 3 Pack(s)

Generic Name-Oxaliplatin, Marketed By-Cipla Ltd, Pack Size-1 Injection, Primary Use-Colon Cancer

Additional Information:

Packaging Details : 1 Injection

View Complete Details

Specialty Pharmaceutical Product Registration

We have a good basket of fast-moving specialty products available for product registration in your region for your exclusive marketing. Our partner manufacturing facilities are USFDA/EMEA/PICs/WHO-GMP certified. We provide dossiers for product registration. Our range includes specialty products of Oncology, Nephrology , HIV, Hepatitis, and other specialty segments.
View Complete Details
Tell Us What are you looking for? Will call you back

Contact Us

  • Nihit Goyal (Pragati Healthcare)
  • Marketing Office - 18, Netaji Subhash Marg, Daryaganj, New Delhi - 110002 rnRegistered Office - 208/A11, Rama Palace, M.G. Road, Agra - 282002
  • Share us via
  • Call 08069182071 Ext. 509